Loading asset research
Q3 2026 earnings · Oct 29
DexCom Inc. Common Stock
DXCMNasdaq · USD · StocksQuote as of · Exchange session not verified$87.91
+0.65%
Today
DXCM
Loading 1D prices…
Market cap
$33.2B
Volume
2.8M
52w high
$92.5952w low
$54.11Company profile
DexCom Inc. Common Stock
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
SAN DIEGO, CA, United States
Employees
11K
Fiscal year end
1231
CIK
1093557
Session & valuation
Open$87.54
Previous close$87.34
Day high$88.26
Day low$87.17
30-day avg. volume4.1M
Outstanding shares377.4M
Diluted EPS$2.09
Latest annual period
P/E (trailing)34.75
P/E (forward)28.14
Price / book12.66
Beta1.42
Dividend yield—
Deterministic peer set
Companies with SEC SIC 3841
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| RMDResMed Inc. Common Stock | $33B | $5.7B | +26.94% | $10.43 | +0.07% | Hold |
| WSTWest Pharmaceutical Services Inc. Common Stock | $25.8B | $3.1B | +16.06% | $6.79 | +1.25% | Buy |
| MDLNMedline Inc. Class A Common Stock | $43.3B | $28.4B | +4069.36% | -$0.01 | -2.68% | Buy |
| BDXBecton Dickinson and Company Common Stock | $49.9B | $14.2B | +3.17% | $1.59 | -0.25% | Hold |
| BSXBoston Scientific Corporation Common Stock | $63B | $20.1B | +14.44% | $1.94 | -0.80% | Buy |